Lista de obras - Andreas Mörner - Dominio Público Uruguay

B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.

artículo científico publicado en 2008

CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates

artículo científico publicado en 2002

CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization

artículo científico publicado en 2008

Detection of macaque perforin expression and release by flow cytometry, immunohistochemistry, ELISA, and ELISpot

article

Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection

article

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

artículo científico publicado en 2004

Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2.

artículo científico publicado en 1999

Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein.

artículo científico publicado en 2008

Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display

artículo científico publicado en 1999

Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.

artículo científico publicado en 2011

Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus

artículo científico publicado en 2010

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

artículo científico publicado en 2014

Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge

article

Novel major histocompatibility complex class I alleles extracted from two rhesus macaque populations

artículo científico publicado en 2010

P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques.

artículo científico publicado en 2009

Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009

artículo científico publicado en 2012

Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

artículo científico publicado en 1999

Productive HIV-2 infection in the brain is restricted to macrophages/microglia

artículo científico publicado en 2003

Reverse transcriptase viral load correlates with RNA in SIV/SHIV-infected macaques.

artículo científico publicado en 2006

Lista de obras de Andreas Mörner

B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.

CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates

CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization

Detection of macaque perforin expression and release by flow cytometry, immunohistochemistry, ELISA, and ELISpot

Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2.

Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein.

Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display

Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.

Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis

Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge

Novel major histocompatibility complex class I alleles extracted from two rhesus macaque populations

P19-08. Immunisation with recombinant HLA class I and II, HIV-1gp140 and SIVp27 antigens elicits protection against SHIV-SF162P4 infection in rhesus macaques.

Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009

Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Productive HIV-2 infection in the brain is restricted to macrophages/microglia

Reverse transcriptase viral load correlates with RNA in SIV/SHIV-infected macaques.